Position in STRO
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,373,450
+$1,237,458 QoQ
Shares Held
41,369
+97.7% QoQ
Ownership
0.249%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 97 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in STRO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. STRO ranks #176 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in STRO
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,373,450 | 41,369 | Shares | Defined | 2026-08-06 | |
| 2025-03-31 | $135,992 | 209,222 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $400,432 | 217,627 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $744,068 | 215,049 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $799,064 | 272,719 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $1,043,468 | 184,685 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $1,126,654 | 262,624 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $907,233 | 261,451 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $1,175,602 | 252,818 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $1,109,926 | 240,244 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $1,928,735 | 238,705 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $865,093 | 155,873 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $713,681 | 136,983 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,238,078 | 150,618 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $2,226,271 | 149,615 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $3,152,343 | 166,879 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $2,855,348 | 153,596 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $2,307,817 | 101,398 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $2,188,693 | 100,815 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $616,697 | 61,363 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $387,262 | 49,905 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $294,310 | 28,854 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||